Darin J. Weber - Mar 1, 2024 Form 4 Insider Report for PROKIDNEY CORP. (PROK)

Role
SVP of Regulatory Development
Signature
/s/ James Coulston, as Attorney-in-Fact
Stock symbol
PROK
Transactions as of
Mar 1, 2024
Transactions value $
$0
Form type
4
Date filed
3/5/2024, 04:12 PM
Previous filing
Feb 6, 2024
Next filing
Apr 16, 2024

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PROK Employee stock option (right to buy) Award $0 +225K $0.00 225K Mar 1, 2024 Class A Ordinary Shares 225K $1.61 Direct F1
transaction PROK Employee stock option (right to buy) Award $0 +117K $0.00 117K Mar 1, 2024 Class A Ordinary Shares 117K $1.61 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests in substantially equal monthly installments over the four year period beginning on March 1, 2024.
F2 The option vests 50% on the 1st anniversary of March 1, 2024 and the remaining 50% vests in substantially equal monthly installments for 12 months thereafter.